SCHEMBL4506232

SCHEMBL4506232

O=C(NC1CCCCC1)c1ccc(OCCCN2CC3CCCC3C2)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.67
▸ NPC1 O15118 3/20 0.56
▸ RAB9A P51151 3/20 0.56
▸ MAPT P10636 1/20 0.56
▸ SLC2A1 P11166 1/20 0.54
▸ HRH2 P25021 1/20 0.53
▸ HRH1 P35367 1/20 0.53
▸ BMPR1B O00238 2/20 0.53
▸ BMPR1A P36894 2/20 0.53
▸ TGFBR1 P36897 2/20 0.53
▸ ACVRL1 P37023 2/20 0.53
▸ ACVR1 Q04771 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ EPHX2 P34913 1/20 0.52
▸ MAOB P27338 2/20 0.50
▸ DAO P14920 1/20 0.50
▸ AOC3 Q16853 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689688 0.99 HRH3 (0.69) HRH3NPC1RAB9AMAPTSLC2A1
Oxalic Acid SCHEMBL4506187 0.96 HRH3 (0.65) HRH3NPC1RAB9AMAPTSLC2A1
SCHEMBL4495175 0.85 HRH3 (0.68) HRH3HRH2HRH1MAOB
SCHEMBL15494258 0.85 HRH3 (0.72) HRH3SLC2A1HRH2HRH1MAOB
SCHEMBL4486197 0.85 HRH3 (0.72) HRH3HRH2HRH1MAOB
SCHEMBL14241012 0.85 HRH3 (0.72) HRH3HRH2HRH1MAOB
SCHEMBL4496452 0.84 HRH3 (0.70) HRH3HRH2HRH1MAOB
SCHEMBL4498063 0.84 HRH3 (0.64) HRH3SLC2A1MAOBPOLB
SCHEMBL4622753 0.83 HRH3 (0.66) HRH3NPC1RAB9AHRH2HRH1
SCHEMBL4622140 0.83 HRH3 (0.66) HRH3NPC1RAB9AHRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 — — US disclosed
EP-1720544-B1 NOVEL AZABICYCLIC DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2008-03-19 — — EP disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 HRH3 9/4885NPC1 2317/4885RAB9A 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback